Article
Design and use of a peptide nucleic acid for detection of the heteroplasmic low-frequency mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) mutation in human mitochondrial DNA.
Clinical chemistry - 1 Dec 2002
Hancock Diane K, Schwarz Frederick P, Song Fenhong, Wong Lee-Jun C, Levin Barbara C
Abstract excerpt
BACKGROUND: Most pathogenic human mitochondrial DNA (mtDNA) mutations are heteroplasmic (i.e., mutant and wild-type mtDNA coexist in the same individual) and are difficult to detect when their concentration is a small proportion of that of wild-type mtDNA molecules. We describe a simple methodology to detect low proportions of the single base pair heteroplasmic mutation, A3243G, that has been associated with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
